Most Recent Additions*

PDF

Editors' State of the Journal: Making Academic Writing Accessible
Nicole Martino, Nancy E. Krusen, and Stacy Smallfield

PDF

When the Storm Clears: Stories of Life Beyond Chronic Illness
Marie Bernard, David Mercer, Linda Bernard, and Simone Bernard

PDF

Measuring Effectiveness of a Mobility Aide on a Medical-Surgical Unit
Jamie L. Granatowicz, Laura N. Rogers, and Leeza A. Struwe

PDF

Chronic In Utero Oxycodone Exposure Alters Placental Small EV Proteome and Fetal Cardiomyopathy-Linked Pathways
Amin Foroughi Nezhad, Dalia Moore, Victoria L. Schaal, Tousif Ahmed Hediyal, Elizabeth Stone, Sree Kolli, Pranavi Athota, Omar Shukri, Sowmya V. Yelamanchili, and Gurudutt Pendyala

PDF

Efficacy and Safety of Epcoritamab in Relapsed or Refractory Large B-cell Lymphoma: 3-Year Update from the EPCORE NHL-1 Trial
Yasmin H. Karimi, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Umar Farooq, Tatyana Feldman, Herve Ghesquieres, Wojciech Jurczak, Kim M. Linton, Tycel Phillips, Julie M. Vose, Won Seog Kim, Pegah Jafarinasabian, Barbara D'Angelo Månsson, David Soong, Andrew J. Steele, Zhu Li, Christian W. Eskelund, Martin Hutchings, and Catherine Thieblemont

PDF

Estimating Short-Term and Long-Term Survival for Patients With Kidney Failure Using a Mixture Survival Model
Nathan Meyer, Maxwell Donelan, Hossein Moradi Rekabdarkolaee, Brandon Varilek, Surachat Ngorsuraches, Patti Brooks, Jerry Schrier, and Semhar Michael

PDF

Midkine (MDK) as a Central Regulator of the Tumor Microenvironment: From Developmental Cytokine to Therapeutic Target
Hareesh B. Nair, Ajay Nair, Ya-Guang Liu, Dileep K. Vijayan, Ramadevi Subramani, Rajkumar Lakshmanaswamy, Suryavathi Viswanadhapalli, Gangadhara R. Sareddy, Surinder K. Batra, and Ratna K. Vadlamudi

PDF

Unlocking the Power of CXCR2 Inhibition to Overcome Gemcitabine Resistance in Pancreatic Cancer
Caitlin Molczyk, Reegan Sturgeon, Sugandha Saxena, Esther Johnson, Rakesh Bhatia, Namita Bhyravbhatla, Sushil Kumar, Surinder K. Batra, and Rakesh K. Singh

PDF

Prolonged QT Interval in HIV-1 Infected Humanized Mice Treated Chronically with Dolutegravir/Tenofovir Disoproxil Fumarate/Emtricitabine
Ali Namvaran, Julian V. Garcia, Mahendran Ramasamy, Kayla Nguyen, Farzaneh Tavakkoli Ghazani, Bryan T. Hackfort, Prasanta Dash, Reagan E. Fisher, Benson J. Edagwa, Santhi Gorantla, and Keshoer R. Bidasee

PDF

All Alone
Rachel Sisley

PDF

Pregnancy Outcomes after Exposure to Tuberculosis Treatment in Phase 3 Clinical Trial, 2016-2020
Ekaterina V. Kurbatova, William C. Whitworth, Kia E. Bryant, Meredith G. Dixon, Kelly E. Dooley, Nigel A. Scott, Rosanna Boyd, Nicole E. Brown, Kimberley N. Chapman Hedges, Wendy Carr, Lakshmi P. Peddareddy, Grace Muzanyi, Rodney Dawson, Ziyad Waja, Neil Martinson, Jyoti S. V. Mathad, Payam Nahid, Susan Swindells, Richard E. Chaisson, Susan E. Dorman, Patrick P. J. Phillips, AIDS Clinical Trials Group A5349, and Tuberculosis Trials Consortium Study 31

*Updated as of 03/17/26.